J&J Risperdal subpoena
Executive Summary
Johnson & Johnson receives subpoena from HHS Office of the Inspector General for documents relating to the atypical antipsychotic Risperdal (risperidone). Boston U.S. Attorney's Office is investigating J&J's sales and marketing practices for the anti-epileptic Topamax (topiramate) (1"The Pink Sheet" Dec. 15, 2003, In Brief). Both products are widely used off-label...